Concomitant ruxolitinib with cytarabine-based induction chemotherapy in secondary acute myeloid leukemia evolving from myeloproliferative neoplasm

Detalles Bibliográficos
Autores principales: Kim, Dong Hyun, Byun, Ja Min, Shin, Dong-Yeop, Kim, Inho, Yoon, Sung-Soo, Koh, Youngil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2023
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10548284/
https://www.ncbi.nlm.nih.gov/pubmed/37621072
http://dx.doi.org/10.5045/br.2023.2023136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10548284/
https://www.ncbi.nlm.nih.gov/pubmed/37621072
http://dx.doi.org/10.5045/br.2023.2023136

Ejemplares similares